The use of plasma proteins as markers of chemical exposure was studied. The specific areas of investigation were the covalent binding of acrolein (107028) to albumin, the rapid quantitation of acrolein and crotonaldehyde (4170303) modified albumin, the susceptibility to degradation of covalently modified albumin, the development of an enzyme linked immunosorbent assay (ELISA) for styrene (100425), and the preparation and detection of styrene-oxide (96093) specific antibodies. The covalent binding of acrolein to human serum albumin showed four new ninhydrin positive peaks. Study of the effects of acrolein on the ultraviolet absorption and the biological function of albumin to bind fatty acid or bromocresol- green, showed that absorption was increased by approximately 80% at 280 nanometers. The authors suggest that more tyrosine and/or tryptophan residues were exposed as a result of the unfolding of the protein through covalent modification of the lysyl and histidyl residues. The preparation of a styrene-oxide albumin conjugate, the generation of polyclonal antibodies in rabbits, and an ELISA procedure for the detection of antibodies were also discussed.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.